Genetic variations and clinical implications of B-thalassemia in Iraqi population
PLOS One · 2026
DOI: 10.1371/journal.pone.0344034 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Ayman Ziadoon Jawad und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Technologies, Al-Manara College for Medical Sciences, Maysan, Iraq. Hauptthemen laut MEDLINE: beta-Thalassemia, beta-Globins, Genetic Variation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
β-thalassemia is a prevalent genetic disorder in Iraq, leading to significant health issues due to reduced hemoglobin production. The DNA sequencing technique was used to explore genetic variations and their clinical implications. Our findings have the potential to inform diagnosis, guide targeted therapeutic approaches, and enhance genetic counseling to reduce long-term morbidity in affected individuals. Peripheral blood samples were collected from 100 patients for analysis. Quantitative measurements included complete blood count (CBC), ferritin, parathyroid hormone (PTH), lactate dehydrogenase (LDH), 25‑hydroxyvitamin D, phosphorus, calcium, and bone mineral density (BMD) measured by dual-energy X-ray absorptiometry (DXA). We detected 18 β-globin mutations in β-thalassemia patients by direct Sanger sequencing, of which two were novel (HBB:c.315 + l08A>G and HBB:c.316-151A > G). Additionally, four mutations (IVS-II-1G > A, IVS-II-5G > C, IVS-I-110G > A, and HBB:c.440A > C) have been previously reported as pathogenic. This research pinpointed four β-globin gene pathogenic mutations as having significant associations with clinical parameters. Hematological parameters (HGB, WBC, RBC indices, RBC count) and biochemical/metabolic markers (phosphorus, PTH, LDH, ferritin, vitamin D3, calcium, ALP) exhibited strong statistical differences ( p < 0.001–0.020) across mutation groups. Bone health markers (BMC, BMD) and red blood cell indices (MCH, MCHC, MCV, MPV) also showed significant variation ( p < 0.001–0.002). In contrast, platelet count (PLT) did not differ significantly ( p = 0.331). These findings highlight mutation specific impacts on hematological, metabolic, and skeletal systems in the studied population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Laboratory Technologies, Al-Manara College for Medical Sciences, Maysan, Iraq.
- Department of Engineering, University of Messina, Messina, Italy.
- Laboratory of Environmental Toxicology-Microbiology and Health, Faculty of Sciences, University of Sfax, Sfax, Tunisia.
- Department of Pediatrics, College of Medicine, Mustansiyriah University, Baghdad, Iraq.
ORCID-Profile: Ayman Ziadoon Jawad
Zitieren
APA
Jawad, A. Z., Chelly, M., Al-Zuhairy, S. H., & Bouaziz, H. (2026). Genetic variations and clinical implications of B-thalassemia in Iraqi population. PLOS One. https://doi.org/10.1371/journal.pone.0344034
Vancouver
Jawad AZ, Chelly M, Al-Zuhairy SH, Bouaziz H. Genetic variations and clinical implications of B-thalassemia in Iraqi population. PLOS One. 2026. doi:10.1371/journal.pone.0344034
BibTeX
@article{Jawad2026,
author = {Jawad, Ayman Ziadoon and Chelly, Meryam and Al-Zuhairy, Salah Hashim and Bouaziz, Hanen},
title = {Genetic variations and clinical implications of B-thalassemia in Iraqi population},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0344034}
}
EUVIMED